NHS Logo
Bedfordshire and Luton Joint Formulary
Bedfordshire Hospitals NHS Foundation Trust
Bedfordshire, Luton and Milton Keynes ICB
Formulary Chapter: 10 - Musculoskeletal and joint diseases
Notes:

Any drug not listed on the Formulary should be considered Non-Formulary - Not recommended for prescribing
10.01
Drugs used in rheumatic diseases and gout
10.01 Drugs used in rheumatic diseases and gout
10.01
Rheumatoid arthritis and other inflammatory disorders
10.01 Rheumatoid arthritis and other inflammatory disorders
10.01
Osteoarthritis and soft-tissue disorders
10.01 Osteoarthritis and soft-tissue disorders
10.01.01
Non-steroidal anti-inflammatory drugs
10.01.01 Non-steroidal anti-inflammatory drugs
10.01.01
Aspirin
10.01.01 Aspirin
10.01.02
Corticosteroids
10.01.02 Corticosteroids
10.01.02.01
Systemic corticosteroids
10.01.02.01 Systemic corticosteroids
10.01.02.02
Local corticosteroids injections
10.01.02.02 Local corticosteroids injections
10.01.03
Drugs which suppress the rheumatic disease process
10.01.03 Drugs which suppress the rheumatic disease process
10.01.03
Gold
10.01.03 Gold
10.01.03
Penicillamine
10.01.03 Penicillamine
10.01.03
Antimalarials
10.01.03 Antimalarials
10.01.03
Drugs affecting the immune response
10.01.03 Drugs affecting the immune response
10.01.03
Cytokine modulators
10.01.03 Cytokine modulators
10.01.03
Sulfasalazine
10.01.03 Sulfasalazine
10.01.04
Gout and cytotoxic-induced hyperuricaemia
10.01.04 Gout and cytotoxic-induced hyperuricaemia
10.01.04
Acute attacks of gout
10.01.04 Acute attacks of gout
10.01.04
Long-term control of gout
10.01.04 Long-term control of gout
10.01.04
Hyperuricaemia associated with cytotoxic drugs
10.01.04 Hyperuricaemia associated with cytotoxic drugs
10.01.05
Other drugs for rheumatic diseases
10.01.05 Other drugs for rheumatic diseases
10.02
Drugs used in neuromuscular disorders
10.02 Drugs used in neuromuscular disorders
10.02.01
Drugs which enhance neuromuscular transmission
10.02.01 Drugs which enhance neuromuscular transmission
10.02.01
Anticholinesterases
10.02.01 Anticholinesterases
10.02.01
Immunosuppressant therapy
10.02.01 Immunosuppressant therapy
10.02.01
Acetylcholine-release enhancers
10.02.01 Acetylcholine-release enhancers
10.02.02
Skeletal muscle relaxants
10.02.02 Skeletal muscle relaxants
10.02.02
Other muscle relaxants
10.02.02 Other muscle relaxants
10.02.02
Nocturnal leg cramps
10.02.02 Nocturnal leg cramps
10.03
Drugs for the treatment of soft-tissue disorders and topical pain relief
10.03 Drugs for the treatment of soft-tissue disorders and topical pain relief
10.03
Extravasation
10.03 Extravasation
10.03.01
Enzymes
10.03.01 Enzymes
10.03.02
Rubefacients, topical NSAIDs, capsaicin, and poultices
10.03.02 Rubefacients, topical NSAIDs, capsaicin, and poultices
10.03.02
Topical NSAIDs and counter-irritants
10.03.02 Topical NSAIDs and counter-irritants
10.03.02
Capsaicin
10.03.02 Capsaicin
10.03.02
Poultices
10.03.02 Poultices